Callisto Pharmaceuticals
Manufacturing · New York, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
420 Lexington Ave Ste 1609, New York, Ne...Phone Number
(212) 297-0170Website
www.callistopharma.comRevenue
<$5 MillionIndustry
About Callisto Pharmaceuticals
Callisto Pharmaceuticals, Inc. is a publicly traded biotechnology company focused on the clinical development of cancer treatments, specifically Annamycin for relapsed leukemia and Atiprimod for relapsed multiple myeloma and bone resorption. The company has completed Phase I/IIa trials for Annamycin and is planning to initiate a Phase IIb trial, while Atiprimod is undergoing Phase I/IIa trials. Additionally, Callisto is developing drugs in preclinical stages for melanoma and gastrointestinal inflammation, as well as a program for biowarfare agent protection. The company operates through subsidiaries and holds exclusive licenses for its key drugs from notable institutions.Explore more
Callisto Pharmaceuticals Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Callisto Pharmaceuticals Tech Stack
A closer look at the technologies used by Callisto Pharmaceuticals
See more technologies
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Callisto Pharmaceuticals
Sign Up For FreeTo access detailed company insights
Callisto Pharmaceuticals, Inc. is a publicly traded biotechnology company focused on the clinical development of cancer treatments, specifically Annamycin for relapsed leukemia and Atiprimod for relapsed multiple myeloma and bone resorption. The company has completed Phase I/IIa trials for Annamycin and is planning to initiate a Phase IIb trial, wh... Read More
